MaxCyte, Inc. (LON:MXCT – Get Free Report) shares passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 346 ($4.35) and traded as low as GBX 264 ($3.32). MaxCyte shares last traded at GBX 264 ($3.32), with a volume of 29,582 shares changing hands.
MaxCyte Price Performance
The stock’s fifty day moving average price is GBX 344.76 and its two-hundred day moving average price is GBX 313.89. The firm has a market capitalization of £348.49 million, a price-to-earnings ratio of -9.67 and a beta of 1.13. The company has a current ratio of 9.81, a quick ratio of 14.38 and a debt-to-equity ratio of 8.59.
About MaxCyte
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients.
Featured Stories
- Five stocks we like better than MaxCyte
- What is the NASDAQ Stock Exchange?
- Chaos and Cash: Finding Opportunity in Volatility
- The Role Economic Reports Play in a Successful Investment Strategy
- Realty Income: An Anchor in Volatile Markets
- What is the Australian Securities Exchange (ASX)
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.
